GlassScriptPhysician profile
Jeffrey G Stepan
NPI 1811316201
$70,877.53
in general payments reported to CMS, 2019-2025
12 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $773 · 2021: $1,409 · 2023: $2,973 · 2024: $1,044 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,600 · Food and Beverage: $1,862 · Travel and Lodging: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,600.00 |
| Food and Beverage | $1,861.50 |
| Travel and Lodging | $134.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $51,671.13 | 2019-2025 | Acumed, Acumed, Innate Implant |
| Arthrex, INC. | $10,410.96 | 2019-2020 | |
| Checkpoint Surgical, INC | $3,365.46 | 2023-2024 | Checkpoint Stimulators |
| Elite Orthopedics, LLC | $2,051.00 | 2019 | |
| Axogen | $1,283.26 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Medwest Associates | $1,200.00 | 2021 | |
| Stryker Corporation | $361.60 | 2019-2025 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Kerecis Limited | $182.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medartis INC. | $128.49 | 2020-2024 | Aptus |
| Integra Lifesciences Corporation | $119.37 | 2021 | |
| Depuy Synthes Sales INC. | $89.97 | 2021 | |
| Lightbody Medical Technologies INC | $13.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Stepan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.